Top Stories

Qatar Airways will launch long-haul flights to twelve new destinations in 2018, including direct flights to Wales in the UK and San Francisco in the U.S. The Doha-based airline's other new destinations next year are - Utapao in Thailand, Chittagong...

Corporate service prices in Japan were up 0.8 percent on year in March, the Bank of Japan said on Tuesday. That was unchanged from the February reading and in line with expectations. On a monthly basis, prices were up 0.6 percent after rising 0.3...


As part of an ongoing effort to roll back financial regulations instituted under former President Barack Obama, President Donald Trump signed presidential memorandums on Friday ordering reviews of key provisions of the Dodd-Frank financial reform law. In...

The Taiwan stock market has moved higher in two straight sessions, advancing more than 85 points or 0.9 percent along the way. The Taiwan Stock Exchange remains just above the 9,715-point plateau, and the market is looking at another firm lead for Tuesday. The...

April17-041717.jpg Here's why CBLI zoomed higher today while OMED tanked.
Asian-Markets2_17Apr17.jpg Asian stock markets are mostly higher on Tuesday after U.S. stocks rose overnight as investors shrugged off geopolitical concerns, while the U.S. dollar strengthened following comments by Treasury Secretary Steven Mnuchin. Nevertheless, weak commodity prices weighed on resources stocks.
Pharma-041817.jpg Shares of OncoMed Pharmaceuticals Inc. (OMED) slipped more than 17% on Monday, following the failure of its phase II trial of Tarextumab in Small Cell Lung Cancer to meet the endpoints.
Asian-Markets1_18Apr17.jpg European markets are seen opening flat to slightly higher on Tuesday as traders return to their desks after a long holiday weekend. With geopolitical tensions still high, Asian stock markets are trading mixed. The dollar rebounded from a five-month...
Trump1-042417.jpg Donald Trump is the least popular president in modern times, according to Washington Post-ABC News poll, as he nears the 100-day mark of his administration on April 29. Trump came to power on January 20. The New York business tycoon stunned the world...
Capitol-042117.jpg Looking to get an investigation into Russian meddling in last year's presidential election back on track, the House Intelligence Committee has sent letters inviting Trump and Obama administration officials to testify before the committee next month.
The month of April witnessed the FDA approving the first ever drug for tardive dyskinesia, a neurological disorder characterized by involuntary muscle movements. Want to know which drugs are awaiting FDA decision in May? More
Sanofi said that the U.S. Food and Drug Administration approved Thymoglobulin [anti-thymocyte globulin (rabbit)], for use in conjunction with concomitant immunosuppression in the prophylaxis, or prevention, of acute rejection in patients receiving a kidney... More
Centrist Emmanuel Macron and far-right nationalist Marine Le Pen won the first round of the French presidential election, triggering a runoff on May 7, according to projections by polling agencies and official partial results. Macron, a first-time...
Uber-Track-042417.jpg Uber has been reportedly tracking user's phones, even after deleting the app. However, the company now assured that it would not continue with such tracking anymore.
Follow RTT
Economic Calendar
04/24/17 19:50Corp Service Price (Y-o-Y)MAR Japan
04/24/17 17:0Consumer Confidence IndexAPR South Korea
04/24/17 9:30CB Coincidence IndexMAR Eurozone
04/24/17 9:30CB Leading IndexMAR Eurozone
04/24/17 9:0CB Coincidence IndexMAR China
04/24/17 9:0CB Leading IndexMAR China
Complete Economic Calendar
FDA Calendar
Event DateSymbolDrug NameEvent Name
07/21/17PBYIPB272 (Neratinib) (NDA)FDA decision on PB272 for the extended adjuvant treatment of patients with early stage HER2-overexpressed/amplified breast cancer
07/19/17AMGNRomosozumab (BLA)FDA decision on Romosozumab for the treatment of osteoporosis in postmenopausal women at increased risk of fracture
07/19/17OCULDEXTENZA (NDA resubmission)FDA decision on DEXTENZA for treatment of ocular pain occurring after ophthalmic surgery
06/30/17RDUSAbaloparatide-SC (NDA)FDA decision on Abaloparatide–SC for postmenopausal women with osteoporosis
06/30/17ARRYBinimetinib (NDA)FDA decision on Binimetinib for patients with NRAS-mutant melanoma.
Complete FDA Calendar